China Health Beta
Was ist das Beta von China Health?
Beta von China Health Group Inc. ist -1.72
Was ist die Definition von Beta?
BETA gibt an, ob eine Aktie mehr oder weniger schwankungsanfällig ist als der Gesamtmarkt. Ein Beta von weniger als 1 zeigt an, dass die Aktie weniger schwankungsanfällig ist als der Markt, während ein Beta von mehr als 1 anzeigt, dass die Aktie mehr schwankungsanfällig ist. Die Schwankungsanfälligkeit wird als Schwankung des Preises um den Mittelwert gemessen.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta von Unternehmen in Health Care Sektor auf HKSE im Vergleich zu China Health
Was macht China Health?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Unternehmen mit beta ähnlich China Health
- All Active Asset Capital hat Beta von -1.79
- On Real International hat Beta von -1.78
- Visionstate hat Beta von -1.78
- Westhaven Ventures hat Beta von -1.76
- Westhaven Ventures hat Beta von -1.75
- Estrella Resources hat Beta von -1.73
- China Health hat Beta von -1.72
- Barclays Bank PLC hat Beta von -1.72
- Surge Exploration hat Beta von -1.71
- Sagalio hat Beta von -1.68
- Golden Pursuit Resources hat Beta von -1.66
- WMCH Global Investment hat Beta von -1.63
- Skychain Technologies hat Beta von -1.63